Health
Merck ends COVID vaccine program, cites inferior immune responses – Reuters
Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental…
(Reuters) – Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental oral antiviral expected by the end of March.
FILE PHOTO: A scientist is seen in the Themis Bioscience laboratory in Vienna, Austria, in this undated handout photo. Themis Bioscience/Martin Wacht/Handout via REUTERS /File Photo
Merck was late to join the race to develop a vaccine to protect against the coronavirus, which…
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General23 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business18 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM